Josic Djuro, Hoffer Lutz, Buchacher Andrea
Octapharma Pharmazeutika Produktions Ges.m.b.H., Oberlaaerstrasse 235, A-1100, Vienna, Austria.
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jun 25;790(1-2):183-97. doi: 10.1016/s1570-0232(03)00082-5.
A review is given of preparative methods for the isolation of the vitamin K-dependent clotting factors II, VII, IX, X and clotting inhibitor protein C, all derived from human plasma. Factor II, activated factor VII and activated protein C are also obtained from recombinant animal cells. The methods for their purification are described. The problem of difference in posttranslational modifications between plasma derived and recombinant protein is discussed with regard to therapeutic proteins.
本文综述了从人血浆中分离维生素K依赖性凝血因子II、VII、IX、X以及凝血抑制蛋白C的制备方法。因子II、活化因子VII和活化蛋白C也可从重组动物细胞中获得。文中描述了它们的纯化方法。针对治疗性蛋白质,讨论了血浆来源蛋白和重组蛋白在翻译后修饰方面的差异问题。